Assessing potential health risks from microcystin toxins in blue-green algae dietary supplements

Environmental Health Perspectives

Volumn 108, Issue 5, 2000, Pages 435-439

  Gilroy, Duncan J ^a   Kauffman, Kenneth W ^a   Hall, Ronald A ^a   Huang, Xuan ^b   Chu, Fun S ^b  

^a OREGON PUBLIC HEALTH DIVISION   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Aphanizomenon flos aquae; Blue green algae; Cyanobacteria; Dietary supplements; Microcystins; Microcystis aeruginosa

Indexed keywords

CYANOGINOSIN; CYANOGINOSIN LR; DRINKING WATER; SURFACE WATER; TUMOR PROMOTER;

ARTICLE; CANADA; CONSUMER; DIET SUPPLEMENTATION; ENERGY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; EXPOSURE; FOOD CONTAMINATION; FOOD INTAKE; HEALTH HAZARD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROCYSTIS AERUGINOSA; MOOD; PRIORITY JOURNAL; PUBLIC HEALTH; RECREATION; RISK ASSESSMENT; TUMOR PROMOTION; UNITED STATES; WATER SAMPLING;

ALGAE; APHANIZOMENON FLOS AQUAE; CHLOROPHYTA; CYANOBACTERIA; FLOS; MICROCYSTIS AERUGINOSA; UNCULTURED CYANOBACTERIUM;

EID: 0033944639     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108435     Document Type: Article

References (51)

1. Lambert TW, Holmes CFB, Hrudey SE. Microcystin class of toxins: health effects and safety of drinking water supplies. Environ Rev 2:167-186 (1994).
2. Carmichael WW, Falconer IR. Diseases related to freshwater blue-green algal toxins, and control measures. In: Algal Toxins in Seafood and Drinking Water (Falconer IR, ed.) London:Academic Press, 1993;187-209.
3. Chorus I, Bartram J, eds. Toxic Cyanobacteria in Water: A Guide to Their Public Health Consequences, Monitoring, and Management. London:St. Edmundsbury Press, 1999.
4. Lawton LA, Codd GA. Cyanobacterial (blue-green algal) toxins and their significance in UK and European waters. J Chartered Inst Water Environ Manage 5:460-465 (1991).
5. Falconer IR. An overview of problems caused by toxic blue-green algae (cyanobacteria) in drinking and recreational water. Environ Toxicol 14:5-12 (1999).
6. Yoo SR, Carmichael WW, Hoehn RC, Hrudey SE. Cyanobacterial (Blue-Green Algal) Toxins: A Resource Guide. Denver, CO:AWWA Research Foundation, American Water Works Association, 1995.
7. Beasley VR, Dahlem AM, Cook WO, Valentine WM, Lovell RA, Hooser SB, Harada K, Suzuki M, Carmichael WW. Diagnostic and clinically important aspects of cyanobacterial (blue-green algae) toxicoses. J Vet Diagn Invest 1:359-365 (1989).
8. Frazier K, Colvin B, Styer E, Hullinger G. Microcystin toxicosis in cattle due to overgrowth of blue-green algae. Vet Human Toxicol 40:23-24 (1998).
9. Jackson ARB, McInnes A, Falconer IR, Runnegar MTC. Clinical and pathological changes in sheep experimentally poisoned by the blue-green alga Microcystis aeruginosa. Vet Pathol 21:102-113 (1984).
10. Hunter PR. Cyanobacteria and human health. J Med Microbiol 36:301-302 (1992).
11. Carmichael WW. Blue-green algae: an overlooked health threat. Health Environ Dig 5:1-4 (1991).
12. Falconer IR, Beresford AM, Runnegar MTC. Evidence of liver damage by toxin from a bloom of the blue-green alga, Microcystis aeruginosa. Med J Aust 1:511-514 (1983).
13. Jochimsen EM, Carmichael WW, An JS, Cardo DM, Cookson ST, Holmes CE, Antunes MB, de Melo Filho DA, Lyra TM, Barreto VS, et al. Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil. N Engl J Med 338:873-878 (1998).
14. Carmichael WW. The toxins of cyanobacteria. Sci Am 270:78-86 (1994).
15. Linderman B. Complicated Child? Simple Options. Romona, CA:Ransom Hill Press, 1995.
16. Chu FS, Huang X, Wei RD, Carmichael WW. Production and characterization of antibodies against microcystins. Appl Environ Microbiol 55:1928-1933 (1989).
17. Chu FS, Huang X, Wei RD. Enzyme-linked immunosorbant assay for microcystins in blue-green algal blooms. J Assoc Off Anal Chem 73:451-456 (1990).
18. Carmichael WW. Toxic Microcystis in the environment. In: Toxic Microcystis (Watanabe MF, Harada KI, Carmichael WW, Fujiki H, eds). New York:CRC Press, 1996;1-11.
19. Dourson ML, Felter SP, Robinson D. Evolution of science-based uncertainty factors in noncancer risk assessment. Regul Toxicol Pharmacol 24:108-120 (1996).
20. Fawell JK, Mitchell RE, Everett DJ, Hill RE. The toxicity of cyanobacterial toxins in the mouse. I: Microcystin-LR. Human Exp Toxicol 18:162-167 (1999).
21. Federal-Provincial Subcommittee on Drinking Water. Cyanobacterial Toxins - Microcystins in Drinking Water. Document for Public Comment. Ottawa, Ontario, Canada:Federal-Provincial Subcommittee on Drinking Water, 1998.
22. WHO. Guidelines for Drinking Water Quality, 2nd ed. Addendum to Vol 2, Health Criteria and Other Supporting Information. Geneva:World Health Organization, 1998.
23. Park J, Chu FS. Unpublished observations.
24. Carmichael WW. Personal communication.
25. Harada K. Chemistry and detection of microcystins. In: Toxic Microcystis (Watanabe MF, Harada KI, Carmichael WW, Fujiki H, eds). New York:CRC Press, 1996;103-148.
26. Abdel-Rahman S, el-Ayouty YM, Kamael HA. Characterization of heptapeptide toxins extracted from Microcystis aeruginosa (Egyptian isolate). Comparison with some synthesized analogs. Int J Pept Protein Res 41:1-7 (1993).
27. Falconer IR, Burch MD, Steffensen DA, Choice M, Coverdale OR. Toxicity of the blue-green alga (cyanobacterium) Microcystis aeruginosa in drinking water to growing pigs, as an animal model for human injury and risk assessment. Environ Toxicol Water Qual 9:131-139 (1994).
28. Kaya K. Toxicology of microcystins. In: Toxic Microcystis (Watanabe MF, Harada KI, Carmichael WW, Fujiki H, eds). New York:CRC Press, 1996;175-202.
29. Falconer IR. Mechanism of toxicity of cyclic peptide toxins from blue-green algae. In: Algal Toxins in Seafood and Drinking Water (Falconer IR, ed). London:Academic Press, 1993;177-186.
30. Falconer IR, Smith JV, Jackson ARB, Jones A, Runnegar MTC. Oral toxicity of a bloom of the cyanobacterium Microcystis aeruginosa administered to mice over periods up to 1 year. J Toxicol Environ Health 24:291-305 (1988).
31. Solter PF, Wollenberg GK, Huang X, Chu FS, Runnegar MT. Prolonged sublethal exposure to the protein phosphatase inhibitor microcystin-LR results in multiple dose-dependent hepatotoxic effects. Toxicol Sci 44:87-96 (1998).
32. Yoshida T, Makita Y, Tsutsumi T, Nagata S, Tashiro F, Yoshida F, Sekijima M, Tamura S, Harada T, Maita K, et al. Immunohistochemical localization of microcystin-LR in the liver of mice: a study on the pathogenesis of microcystin-LR-induced hepatotoxicity. Toxicol Pathol 26:411-418 (1998).
33. Nishiwaki R, Ohta T, Sueoka E, Suganuma M, Harada K, Watanabe MF, Fujiki H. Two significant aspects of microcystin-LR: specific binding and liver specificity. Cancer Lett 83:283-289 (1994).
34. Lin J, Chu FS. Kinetics of distribution of microcystin-LR in serum and liver cytosol of mice: an immunochemical analysis. J Agric Food Chem 42:1035-1040 (1994).
35. Robinson NA, Pace JG, Matson CF, Miura GA, Lawrence WB. Tissue distribution, excretion, and hepatic biotransformation of microcystin-LR in mice. J Pharmacol Exp Ther 256:176-182 (1991).
36. Runnegar M, Berndt N, Kong S, Lee EYC, Zhang L. In vivo and in vitro binding of microcystin to protein phosphatases 1 and 2A. Biochem Biophys Res Commun 216:162-169 (1995). s
37. Falconer IR. Tumor promotion and liver injury caused by oral consumption of cyanobacteria. Environ Toxicol Water Qual 6:177-184 (1991) .
38. Nishiwaki-Matsushima R, Ohta T, Nishiwaki S, Suganuma M, Kohyama K, Ishikawa T, Carmichael WW, Fujiki H. Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR. J Cancer Res Clin Oncol 118:420-424 (1992).
39. Fujiki H, Sueoka E, Suganuma M. Carcinogenesis of microcystins. In: Toxic Microcystis (Watanabe MF, Harada KI, Carmichael WW, Fujiki H, eds). New York:CRC Press, 1996;202-232.
40. Takai A, Sasaki K, Nagai H, Mieskes G, Isobe M, Isono K, Yasumoto T. Inhibition of specific binding of okadaic acid to protein phosphatase 2A by microcystin-LR, calyculin-A and tautomycin: method of analysis of interactions of tight-binding ligands with target protein. Biochem J 306:657-665 (1995).
41. Ueno Y, Nagata S, Tsutsumi T, Hasegawa A, Watanabe MF, Park H, Chen GC, Chen G, Yu S. Detection of microcystins, a blue-green algal hepatotaxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis 17:1317-1321 (1996).
42. Yu S. Primary prevention of hepatocellular carcinoma. J Gastroenterol Hepatol 10:674-682 (1995).
43. Wu C, Maurer C, Wang Y, Xue S, Davis DL. Water pollution and human health in China. Environ Health Perspect 107:251-256 (1999).
44. Codd GA, Ward CJ, Bell SG. Cyanobacterial toxins: occurrence, modes of action, health effects and exposure routes. In: Applied Toxicology: Approaches Through Basic Science. Proceedings of the 1996 EUROTOX Meeting, 22-25 September 1996, Alicante, Spain. Archives of Toxicology Supplement 19 (Seiler JP, Vilanova E, eds). Berlin:Springer-Verlag, 1997;399-410.
45. Huang X, Chu FS. unpublished observations.
46. Dietary Supplement Health and Education Act. Public Law 103-417, Section 13, 1994.
47. Matthews HB, Lucier GW, Fisher KD. Medicinal herbs in the United States: research needs. Environ Health Perspect 107:773-778 (1999).
48. Angell M, Kassirer JP. Alternative medicine - the risks of untested and unregulated remedies. N Engl J Med 339:839-841 (1998).
49. Taylor D. Herbal medicine at a crossroads. Environ Health Perspect 104:924-928 (1996).
50. Kurtzweil P. An FDA guide to dietary supplements. FDA Consumer Sept-Oct:28-35 (1998).
51. U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Special Nutritionals. The Special Nutritionals Adverse Event Monitoring System Available: http://vm.cfsan.fda.gov/-dms/aems.html [cited 7 June 1999].